Cargando…
Nanomotor-based H(2)S donor with mitochondrial targeting function for treatment of Parkinson's disease
Reduction of endogenous hydrogen sulfide (H(2)S) is considered to have an important impact on the progress of Parkinson's disease (PD), thus exogenous H(2)S supplementation is expected to become one of the key means to treat PD. However, at present, it is difficult for H(2)S donors to effective...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
KeAi Publishing
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522957/ https://www.ncbi.nlm.nih.gov/pubmed/37771932 http://dx.doi.org/10.1016/j.bioactmat.2023.09.001 |